Cargando…

Synthetic Cannabinoid Abuse and a Rare Alpha-1-Antitrypsin Mutant Causing Acute Fulminant Hepatitis: A Case Report and Review of the Literature

Synthetic cannabinoids (SCs) abuse is on the rise because they are easily obtained over the counter; they are potent psychoactive compounds and routine drug testing does not detect them. As their abuse is on the rise, so are their detrimental side effects; however, the occurrence of acute hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knowles, Kurt J., Wei, Eric X., Seth, Abhishek, Bienvenu, John, Morris, James, Manas, Kenneth, Jordan, Paul, Boktor, Moheb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733121/ https://www.ncbi.nlm.nih.gov/pubmed/29333304 http://dx.doi.org/10.1155/2017/9627452

Ejemplares similares

Diabetic Ketoacidosis-induced Hypertriglyceridemic Acute Pancreatitis Treated with Plasmapheresis—Recipe for Biochemical Disaster Management
por: Seth, Abhishek, et al.
Publicado: (2014)

The Aftermath of a Hepatic Artery Aneurysm—A Rare Etiology of Biliary Obstruction!
por: Linzay, Catherine, et al.
Publicado: (2017)

Pyogenic Liver Abscess Caused by Methicillin-Susceptible Staphylococcus aureus in a 21-Year-Old Male
por: Igbinedion, Samuel, et al.
Publicado: (2018)

Autoimmune Hepatitis (AIH) in Acquired Immune Deficiency Syndrome (AIDS): A Case Report and Review of Literature
por: Roussel, Jordan, et al.
Publicado: (2019)

Emerging drugs of abuse: current perspectives on synthetic cannabinoids
por: Debruyne, Danièle, et al.
Publicado: (2015)

Acute Liver Injury Induced by Synthetic Cannabinoid Abuse
por: Shahbaz, Amir, et al.
Publicado: (2018)

Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers
por: D’Errico, Stefano, et al.
Publicado: (2022)

Liver Cholestasis Secondary to Syphilis in an Immunocompetent Patient
por: Hussain, Nazneen, et al.
Publicado: (2018)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

Alpha 1-antitrypsin and survival in hepatocellular carcinoma.
por: Tzonou, A., et al.
Publicado: (1990)

Abuse Potential of Synthetic Cannabinoids: AM-1248, CB-13, and PB-22
por: Hur, Kwang-Hyun, et al.
Publicado: (2021)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
por: Carroll, Tomás P, et al.
Publicado: (2011)

Fulminant hepatic failure in the setting of progressive ANCA-associated vasculitis associated with a rare alpha-1 antitrypsin phenotype, ’PiEE'
por: Reilkoff, Ronald, et al.
Publicado: (2018)

A Case of Acute Life-Threatening Pulmonary Hemorrhage from Synthetic Cannabinoid Abuse
por: Imtiaz, Muhammad, et al.
Publicado: (2019)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

Synthetic cannabinoids
por: Bilici, Rabia
Publicado: (2014)

Causal and Synthetic Associations of Variants in the SERPINA Gene Cluster with Alpha1-antitrypsin Serum Levels
por: Thun, Gian Andri, et al.
Publicado: (2013)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
por: Shaik, Noor Ahmad, et al.
Publicado: (2022)

Assessment of the Abuse Liability of Synthetic Cannabinoid Agonists JWH-030, JWH-175, and JWH-176
por: Tampus, Reinholdgher, et al.
Publicado: (2015)

Abuse of Synthetic Cannabinoids and Cathinones in a Patient on Buprenorphine-Naloxone Treatment: A Case Report
por: Awasthi, Harshal
Publicado: (2023)

Description of 22 new alpha-1 antitrypsin genetic variants
por: Renoux, Céline, et al.
Publicado: (2018)

alpha1-Antitrypsin deficiency and hepatocellular cancer.
por: Kew, M. C., et al.
Publicado: (1978)

Alpha 1-antitrypsin retention in an ectopic liver
por: Dettmer, Matthias, et al.
Publicado: (2011)

Polymorphism of alpha-1-antitrypsin in hematological malignancies
por: Topic, Aleksandra, et al.
Publicado: (2009)

Alpha-1-Antitrypsin in Pathogenesis of Hepatocellular Carcinoma
por: Topic, Aleksandra, et al.
Publicado: (2012)

Alpha‐1‐antitrypsin in cell and organ transplantation
por: Berger, Mel, et al.
Publicado: (2018)

Alpha-1 Antitrypsin Deficiency: The Learning Goes On
por: Stockley, Robert. A.
Publicado: (2020)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020)

Alpha-1 Antitrypsin Deficiency: Home Therapy
por: Annunziata, Anna, et al.
Publicado: (2021)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
por: Sark, Annelot D., et al.
Publicado: (2022)

Effectiveness of the synthetic cannabinoids seminar
por: Seyit, Murat, et al.
Publicado: (2016)

Synthetic cannabinoids and renal injury
por: Alp, Alper
Publicado: (2015)

alpha 1-Antitrypsin deficiency and susceptibility to lung disease.
por: Evans, H E, et al.
Publicado: (1979)

Alpha 1 Antitrypsin Deficiency in Infants with Neonatal Cholestasis
por: Monajemzadeh, Maryam, et al.
Publicado: (2013)

Alpha-1 antitrypsin genotypes in breast cancer patients
por: El-Akawi, Z, et al.
Publicado: (2005)

Discovery of an Inhibitor of Z-Alpha1 Antitrypsin Polymerization
por: Berthelier, Valerie, et al.
Publicado: (2015)

Identification of a novel alpha1-antitrypsin variant
por: de Seynes, Camille, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fn8tg0uh5srq97g5ekuv84sfb8